CClinicalTrials.gg
CompletedNCT01749696Updated May 9, 2014

Alterations in Connective Tissue in Patients With or Without Pelvic Organ Prolapse

An observational study in Pelvic Organ Prolapse, sponsored by Turku University Hospital. Completed at 1 site in Finland. Open to female participants. Per ClinicalTrials.gov, last updated 2014-05-09.

Sponsored by Turku University Hospital · Observational

Study type
Observational
Enrollment
78
Sex
Female
01

Study summary

The aim of our study is to investigate the alterations in connective tissue of vaginal wall in patients with and without pelvic organ prolapse (POP).

Read the detailed description

The tissue samples were taken from the anterior wall of vagina in the midline close to cervix or apex. The tissue samples were collected from the vaginal wall of the patients with pelvic organ prolapse (n=39) during vaginal prolapse surgery. Control samples (n=39) were taken from patients after vaginal or laparoscopic removal of the uterus.

The formalin-fixed and paraffin embedded tissue samples were stained with Verhoeff van Gieson and Movat's pentachrome. Samples were examined by pathologist and gynecologist blinded as to the other investigator and to the pelvic organ prolapse status. In case of discrepancy investigators evaluated the samples together to gain consensus.

02

Conditions studied

  • Pelvic Organ Prolapse

Keywords

  • Pelvic organ prolapse
  • Connective tissue
  • Elastin
  • Collagen
03

In context

Prolapse

676 studies on the registry are indexed under Prolapse; 79 are open to participants now.

This study's enrollment of 78 is below the median of 126 across 222 observational studies indexed under Prolapse.

Browse Prolapse studies →

Lead sponsor

Turku University Hospital is the lead sponsor of 280 studies on the registry; 65 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

39 patients with pelvic organ prolapse and as controls 39 patients without prolapse.

Inclusion criteria

  • surgery for pelvic organ prolapse
  • hysterectomy due to other benign reasons than pelvic organ prolapse

Exclusion criteria

Exclusion Criteria:

  • surgery due to malignancy
05

Study design

Enrollment
78 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients with pelvic organ prolapse

    Patients, who were operated on because of pelvic organ prolapse.

  • Patients without pelvic organ prolapse

    Patients, who had hysterectomy due to other reasons than pelvic organ prolapse.

06

What researchers measure

Primary outcomes

  1. The elastin content in tissue samples in patients with or without pelvic organ prolapse.

    Time frame: september 2012

Secondary outcomes

  1. The collagen content in tissue samples in women with or without pelvic organ prolapse.

    Time frame: September 2012

07

Study locations

1 site
  • Department of Obstetrics and Gynecology, Turku University Central Hospital
    Turku, 20520, Finland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 9, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01749696
Lead sponsor
Turku University Hospital
Responsible party
Sponsor
First posted
Dec 17, 2012
Start date
Nov 2009
Primary completion
Sep 2012
Completion
Apr 2014
Last update
May 9, 2014
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion